|
Delayed
OTC Markets
07:02:07 14/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0300 USD | +5.26% |
|
+7.53% | +15.38% |
| 19/05 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 17/11 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +5.26% | +7.53% | +25.00% | -9.09% | +15.38% | -81.25% | -95.49% | -99.45% | -99.46% | 75.54L | |
| +3.23% | +1.33% | +5.82% | +4.51% | +12.08% | +48.27% | +95.33% | +408.90% | +1,419.50% | 1,04000Cr | |
| +0.46% | -3.06% | -5.93% | -1.31% | +21.06% | +31.27% | +59.04% | +56.47% | +113.11% | 60TCr | |
| +2.10% | +2.76% | +6.52% | +13.92% | +22.04% | +21.70% | +89.40% | +156.04% | +363.44% | 48TCr | |
| +1.99% | +0.92% | -0.52% | +19.31% | +36.90% | +70.13% | +38.37% | +83.97% | +131.90% | 35TCr | |
| +2.53% | +2.33% | +1.94% | +12.66% | +12.25% | +28.72% | +46.10% | +3.15% | +56.23% | 35TCr | |
| +1.94% | +1.30% | +6.72% | -0.69% | +10.93% | +16.86% | +39.43% | +59.01% | +61.25% | 27TCr | |
| +2.49% | -0.28% | -0.07% | -1.76% | -11.92% | -4.65% | +10.70% | +37.80% | +145.52% | 24TCr | |
| +2.34% | +2.00% | +10.44% | +18.60% | +28.73% | +43.38% | +46.87% | +103.76% | +160.24% | 22TCr | |
| +1.44% | +2.00% | +2.31% | +15.19% | +22.04% | +26.43% | +89.13% | +119.79% | +105.90% | 18TCr | |
| +0.13% | +1.08% | -8.47% | -19.72% | -21.09% | -28.84% | -63.69% | -20.63% | +89.76% | 17TCr | |
| +2.54% | +3.18% | +4.22% | +19.13% | +16.02% | +17.82% | -13.17% | -30.67% | -11.54% | 16TCr | |
| +1.46% | -2.64% | -5.24% | +3.35% | +8.59% | +19.42% | +31.63% | +170.64% | +521.34% | 12TCr | |
| +1.38% | -4.18% | -10.76% | +0.45% | +6.05% | +30.61% | +0.06% | -0.86% | +14.94% | 12TCr | |
| +0.88% | +6.70% | +6.62% | +20.90% | +18.41% | +24.22% | +113.33% | +378.33% | +503.29% | 11TCr | |
| +0.54% | -0.88% | -5.63% | -5.72% | -13.95% | -15.20% | -31.48% | -15.39% | +3.91% | 9.49TCr | |
| +1.95% | -0.56% | -3.99% | -7.29% | -2.41% | +8.73% | +19.24% | +1.61% | -15.77% | 9.31TCr | |
| -1.29% | +10.75% | +48.34% | +222.67% | +637.90% | +728.98% | +136.68% | -34.43% | - | 8.63TCr | |
| +1.76% | +2.24% | -4.41% | +15.64% | -1.70% | +32.50% | -10.07% | +36.55% | +104.13% | 7.52TCr | |
| +2.71% | +0.82% | +8.23% | +1.29% | +15.25% | +22.50% | -5.39% | -26.48% | +44.86% | 6.7TCr | |
| Average | +1.83% | +1.96% | +4.06% | +16.10% | +41.63% | +52.08% | +29.80% | +69.41% | +195.40% | 24.21TCr | |
| Weighted average by Cap. | +2.01% | +2.23% | +2.54% | +10.31% | +24.95% | +42.30% | +53.80% | +141.92% | +428.65% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
